MAPT and Stroke: An analysis of these biomarkers found increased levels of CSF tau among patients suffering from acute ischemic events detected by combined clinical and MRI assessments.9 CSF p-tau levels were similar between individuals with MCI and those with stroke, suggesting some neurodegeneration within both groups, although this biomarker was more altered in AD.